We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+26.44%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$6.18B
AUM Growth
+$2.27B
(+58%)
Cap. Flow
+$1.4B
Cap. Flow
% of AUM
22.72%
Top 10 Holdings %
Top 10 Hldgs %
7.21%
Holding
2,699
New
906
Increased
683
Reduced
582
Closed
520
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$40.9M |
| 2 |
Pfizer
PFE
|
+$37.8M |
| 3 |
Honeywell
HON
|
+$33.2M |
| 4 |
JPMorgan Chase
JPM
|
+$32.4M |
| 5 |
CME Group
CME
|
+$31.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Exelon
EXC
|
+$33.3M |
| 2 |
PayPal
PYPL
|
+$33.1M |
| 3 |
Amazon
AMZN
|
+$32.1M |
| 4 |
PPG Industries
PPG
|
+$27.6M |
| 5 |
Autodesk
ADSK
|
+$26.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.23% |
| 2 | Consumer Discretionary | 14.63% |
| 3 | Healthcare | 13.67% |
| 4 | Financials | 11.93% |
| 5 | Industrials | 11.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
POLY
1851
DELISTED
Plantronics, Inc.
POLY
| $181K | ﹤0.01% |
12,319
-378,179
| -97% | -$4.93M |
|
|
KALV
1852
DELISTED
KalVista Pharmaceuticals
KALV
| $180K | ﹤0.01% |
14,853
-61,057
| -80% | -$649K |
|
1853
Dianthus Therapeutics
DNTH
$5.68B
| $179K | ﹤0.01% |
1,487
+55
| +4% | +$7.75K |
|
1854
Delcath Systems
DCTH
$422M
| $178K | ﹤0.01% |
+17,324
| New | +$140K |
|
1855
Kura Sushi USA
KRUS
$537M
| $178K | ﹤0.01% |
+12,459
| New | +$178K |
|
1856
Titan International
TWI
$516M
| $178K | ﹤0.01% |
122,178
+109,997
| +903% | +$148K |
|
|
LTRPA
1857
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $178K | ﹤0.01% |
83,493
+55,171
| +195% | +$126K |
|
|
OSG
1858
Octave Specialty Group
OSG
$252M
| $177K | ﹤0.01% |
12,343
-30,240
| -71% | -$442K |
|
1859
Fortress Biotech
FBIO
$111M
| $177K | ﹤0.01% |
+4,394
| New | +$163K |
|
|
NEX
1860
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $176K | ﹤0.01% |
71,873
-28,227
| -28% | -$69K |
|
|
RUBY
1861
DELISTED
Rubius Therapeutics, Inc
RUBY
| $176K | ﹤0.01% |
+29,402
| New | +$174K |
|
|
FRTA
1862
DELISTED
Forterra, Inc
FRTA
| $176K | ﹤0.01% |
15,753
-61,751
| -80% | -$509K |
|
|
CETV
1863
DELISTED
Central European Media Enterprises Ltd
CETV
| $176K | ﹤0.01% |
+49,662
| New | +$184K |
|
1864
Center Bancorp
CNOB
$1.63B
| $175K | ﹤0.01% |
+10,867
| New | +$155K |
|
|
LITS
1865
Lite Strategy Inc
LITS
$33.6M
| $174K | ﹤0.01% |
2,101
-1,724
| -45% | -$105K |
|
1866
Puma Biotechnology
PBYI
$406M
| $174K | ﹤0.01% |
+16,658
| New | +$172K |
|
1867
eGain
EGAN
$176M
| $173K | ﹤0.01% |
+15,590
| New | +$142K |
|
1868
Red Robin
RRGB
$134M
| $172K | ﹤0.01% |
+16,894
| New | +$213K |
|
1869
Exagen
XGN
$113M
| $172K | ﹤0.01% |
13,855
-2,318
| -14% | -$31.4K |
|
1870
Actinium Pharmaceuticals
ATNM
$27M
| $171K | ﹤0.01% |
+16,188
| New | +$123K |
|
1871
Central Pacific Financial
CPF
$997M
| $170K | ﹤0.01% |
+10,586
| New | +$168K |
|
1872
Digimarc Corp
DMRC
$133M
| $170K | ﹤0.01% |
+10,602
| New | +$170K |
|
1873
Ecovyst
ECVT
$1.36B
| $170K | ﹤0.01% |
+12,845
| New | +$151K |
|
1874
Dana Inc
DAN
$2.91B
| $169K | ﹤0.01% |
+13,900
| New | +$151K |
|
1875
News Corp Class B
NWS
$16.4B
| $168K | ﹤0.01% |
+14,099
| New | +$153K |
|
Similar funds
Squarepoint's Q2 2020 Portfolio in Review
As of Q2 2020, Squarepoint held 2,699 positions worth $6.18B, up 58% from $3.91B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
Squarepoint deployed $1.4B of net new capital in Q2 2020, opening 906 new positions and adding to 683 existing holdings. Its largest new stake was Citigroup: 482,502 shares worth $24.7M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was PayPal, an estimated $33.1M trimmed.
- Squarepoint's largest Q2 2020 buy was Citigroup: 482,502 shares worth $24.7M.
- Squarepoint added most to Biogen in Q2 2020, an estimated $40.9M increase.
- Squarepoint's biggest Q2 2020 reduction was PayPal, cutting an estimated $33.1M.
- Squarepoint fully exited Exelon in Q2 2020, selling an estimated $33.3M.
- Squarepoint's ten largest holdings make up 7.2% of its $6.18B portfolio in Q2 2020.
- Squarepoint opened 906 new positions and closed 520 in Q2 2020.
- Squarepoint's portfolio value rose 58% quarter-over-quarter to $6.18B.
Based on Squarepoint's 13F filing for Q2 2020, filed 14 Aug 2020.